BE2013C004I2 - Phosphonocephem derivatives, process for the preparation of the same, and use thereof - Google Patents

Phosphonocephem derivatives, process for the preparation of the same, and use thereof

Info

Publication number
BE2013C004I2
BE2013C004I2 BE2013C004C BE2013C004C BE2013C004I2 BE 2013C004 I2 BE2013C004 I2 BE 2013C004I2 BE 2013C004 C BE2013C004 C BE 2013C004C BE 2013C004 C BE2013C004 C BE 2013C004C BE 2013C004 I2 BE2013C004 I2 BE 2013C004I2
Authority
BE
Belgium
Prior art keywords
group
substituted
preparation
same
hydrogen atom
Prior art date
Application number
BE2013C004C
Other languages
English (en)
French (fr)
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18417716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2013C004(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of BE2013C004I2 publication Critical patent/BE2013C004I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
BE2013C004C 1997-12-19 2013-01-08 Phosphonocephem derivatives, process for the preparation of the same, and use thereof BE2013C004I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35149997 1997-12-19
PCT/JP1998/005709 WO1999032497A1 (fr) 1997-12-19 1998-12-17 Derives de phosphonocephem, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
BE2013C004I2 true BE2013C004I2 (en) 2018-01-29

Family

ID=18417716

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2013C004C BE2013C004I2 (en) 1997-12-19 2013-01-08 Phosphonocephem derivatives, process for the preparation of the same, and use thereof

Country Status (19)

Country Link
US (1) US6417175B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP1043327B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (3) JP3467418B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100384047B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (2) CN1194980C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE430155T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU1683299A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE2013C004I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2314564C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (2) CY1109276T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69840796D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1043327T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2325139T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR13C0008I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU92134I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL300568I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1043327E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW473479B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999032497A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1310502E (pt) * 2000-08-10 2009-07-31 Takeda Pharmaceutical Composto de fosfonocefem
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN101357929B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有巯基噻二唑的头孢菌素衍生物
BRPI0816412A2 (pt) 2007-09-21 2017-05-16 Forest Laboratories Holdings Ltd forma de dosagem, e, método para tratar uma infecção bacteriana
MX2011002185A (es) 2008-08-28 2011-04-04 Astrazeneca Ab Composiciones y metodos de tratamiento que comprenden ceftarolina.
CA2753387C (en) * 2009-02-23 2017-01-24 Forest Laboratories Holdings Limited Novel cephem compounds useful for the treatment of bacterial infections
CN102781451A (zh) 2009-09-21 2012-11-14 阿斯利康(瑞典)有限公司 使用头孢洛林用于治疗细菌感染的组合物和方法
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
KR102143660B1 (ko) 2011-06-17 2020-08-11 화이자 안티-인펙티브스 에이비 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법
US20140350240A1 (en) 2011-12-07 2014-11-27 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
USRE47787E1 (en) * 2012-10-19 2019-12-31 Sandoz Ag Process for preparing ceftaroline fosamil
CN102977124B (zh) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法
WO2014096176A1 (en) * 2012-12-20 2014-06-26 Sandoz Ag Novel crystalline forms of ceftaroline fosamil
KR102428252B1 (ko) 2014-02-21 2022-08-02 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 치료적 투여용 수용성 o-카보닐 포스포르아미데이트 전구약물
CN106565784B (zh) * 2016-10-31 2019-02-26 瑞阳制药有限公司 头孢洛林酯二钠盐的纯化方法
CN110872322B (zh) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 乙酸头孢罗膦一水合物及其中间体的制备方法
CN113072567B (zh) * 2021-03-26 2022-10-14 海南海灵化学制药有限公司 一种拉氧头孢钠合成工艺
CN113214323A (zh) * 2021-04-30 2021-08-06 瑞阳制药股份有限公司 分段式头孢罗膦高效稳定析晶方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) * 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法
US4268509A (en) 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
JPS5511600A (en) * 1978-07-10 1980-01-26 Fujisawa Pharmaceut Co Ltd Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same
FR2511372A1 (fr) 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine et leur preparation
JPS5931791A (ja) * 1982-07-19 1984-02-20 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS62238291A (ja) * 1986-04-10 1987-10-19 Fujisawa Pharmaceut Co Ltd セフエム化合物および医薬として許容されるその塩
US4978663A (en) * 1989-08-16 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
JP3514495B2 (ja) 1992-10-02 2004-03-31 エーザイ株式会社 ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
JP3927262B2 (ja) * 1995-07-19 2007-06-06 武田薬品工業株式会社 セフェム化合物、その製造法および抗菌組成物
JPH10265488A (ja) * 1997-03-27 1998-10-06 Takeda Chem Ind Ltd ホスフォノセフェム誘導体

Also Published As

Publication number Publication date
DK1043327T3 (da) 2009-08-17
LU92134I2 (fr) 2013-03-18
WO1999032497A1 (fr) 1999-07-01
CN1679595A (zh) 2005-10-12
EP1043327B1 (en) 2009-04-29
JP2009114202A (ja) 2009-05-28
EP1043327A1 (en) 2000-10-11
CY2013003I2 (el) 2015-08-05
JPH11255772A (ja) 1999-09-21
KR100384047B1 (ko) 2003-05-14
FR13C0008I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2013-03-22
TW473479B (en) 2002-01-21
DE69840796D1 (de) 2009-06-10
ATE430155T1 (de) 2009-05-15
NL300568I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2016-01-18
FR13C0008I2 (fr) 2013-08-16
ES2325139T3 (es) 2009-08-26
CA2314564C (en) 2008-11-18
PT1043327E (pt) 2009-07-02
CN1679595B (zh) 2010-05-12
US6417175B1 (en) 2002-07-09
KR20010015885A (ko) 2001-02-26
AU1683299A (en) 1999-07-12
EP2080765A1 (en) 2009-07-22
EP1043327A4 (en) 2001-12-12
CY2013003I1 (el) 2014-07-02
NL300568I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2016-01-18
CN1194980C (zh) 2005-03-30
CA2314564A1 (en) 1999-07-01
JP3467418B2 (ja) 2003-11-17
JP2001048893A (ja) 2001-02-20
CY1109276T1 (el) 2014-07-02
CN1282335A (zh) 2001-01-31

Similar Documents

Publication Publication Date Title
BE2013C004I2 (en) Phosphonocephem derivatives, process for the preparation of the same, and use thereof
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
IE892340L (en) 4-oxoquinoline-3-carboxylic acid derivatives, their¹preparation and their use
AU3461697A (en) Heterocyclic compounds, their production and use
HUT70159A (en) Oxazolidinedion derivatives, pharmaceutical compositions containing them, their production and use
HUT54685A (en) Process for producing condensed heterocyclic compounds, salts and intermediates, and fungicide compositions containing them
AU8345491A (en) Heterocyclic derivatives
CA2219692A1 (en) S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
WO2006103342A3 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
IE901350L (en) Diaminoethylene compounds
AU582553B2 (en) 11-substituted 5H,11H-pyrrolo``2,1-c````1,4``benzoxazepines, a process for their preparation and their use as medicaments
CA2334727A1 (en) Tetrahydroquinoline derivatives as glycine antagonists
IE891199L (en) 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions¹containing them
CA2191874A1 (en) Novel processes and intermediates for the preparation of piperazine derivatives
AU2148595A (en) 4,6-di-t-butyl-2,3-dihydrobenzothiophene derivative
AU671163B2 (en) Alkyl substituted heterocyclic compounds
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
IE781467L (en) 4"-ureido-oleandomycin derivatives
CA2093510A1 (en) Oxysulfonyl carbamates
IE891261L (en) Heterotetracyclic lactam derivatives
EP0402472A4 (en) Pyrrole derivatives and process for their preparation
AU5910690A (en) Method of treating diabetes mellitus